What is the betaine anhydrous dosage?
| Label | Supplied | One level scoop |
|---|---|---|
| Eton1 | 180 g bottle with a measuring scoop | 1.5 cc = 1 g |
| Cystadane3 | 180 g bottle with a measuring scoop | 1.7 mL = 1 g |
How betaine anhydrous is supplied and measured
The table is set at the top of the page
Searches of DailyMed, PubMed and the Health Canada monograph returned no label with tablet or capsule strengths for the supplement. The trials give two capsule strengths: 500 mg of betaine per capsule in the Zawieja trial of 43 participants, and 0.42 g of betaine per capsule in the Cholewa trial, with 11 on betaine and 12 on placebo.45
How the powder is mixed and taken
It says to shake the bottle lightly, measure the scoops for the dose and replace the cap tightly to protect from moisture.1 The measured powder is mixed with 4 to 6 ounces (120 to 180 mL) of water, juice, milk or formula until dissolved, or with food, and taken immediately.1 The Cystadane label gives the same 4 to 6 ounces.3
Labelled dose, schedule and stepping
The Eton label's only indication is homocystinuria, and it says physicians knowledgeable in homocystinuria are to direct therapy.1 For adults and children 3 years and older it gives 6 grams per day, in divided doses of 3 grams twice daily.1 For children under 3 years it starts at 100 mg/kg/day in two doses, increased weekly by 50 mg/kg.1 For all ages it says to increase the dose gradually until plasma total homocysteine is undetectable or small, with a first response usually within several days and steady state within a month.1 Doses up to 20 grams/day have been needed in some patients, but one in vitro pharmacokinetic and pharmacodynamic simulation study showed minimal benefit above twice-daily dosing and 150 mg/kg/day.1
Doses used in human trials
The authors of the Nieman trial of 21 cyclists write that betaine doses of 0.5 to 20 g/d have been investigated, with 1.5 to 6 g/d reported sufficient to increase plasma betaine and methionine and lower homocysteine within 2 weeks.6
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Zawieja4 | 2.5 g/day (three 500 mg capsules in the morning, two in the evening) or 5 g/day (four, three and three), each also against placebo | 43 (24 on 2.5 g, 19 on 5 g) | three weeks per arm, three-week washout |
| Cholewa5 | 2.5 g/day as three capsules (1.25 g) twice a day, against placebo | 11 on betaine, 12 on placebo | 6 weeks |
| Imbard7 | 100 versus 250 mg/kg/day, crossover | Eleven children with pyridoxine non-responsive CBS or cblC deficiency who completed (5 pnrCBS and 6 cblC) | one month each, one-week wash-out |
| Grizales8 | 3300 mg twice daily for 10 days, then 4950 mg twice daily, against placebo | 27 persons with obesity and prediabetes | 10 days, then 12 weeks |
| Nieman6 | 3 g/day against placebo | 21 cyclists | 2 weeks per arm, 2-week washout |
| Schwab (single doses)9 | 1, 3 and 6 g, each mixed with 150 mL orange juice after a 12-hour fast | 10 healthy volunteers (3 men, 7 women), crossover | Single doses |
| Schwab (12 weeks)10 | 6 g/d against placebo, on a hypoenergetic diet | Forty-two obese subjects | 12 weeks |
In the Schwab single-dose trial of 10 healthy volunteers, single doses of 3 and 6 g lowered plasma homocysteine, unlike 1 g.9 From the eleven children who completed their trial, the Imbard authors concluded there was no overt benefit to raising betaine above 100 mg/kg/day to lower homocysteine in pnrCBS and cblC deficiencies.7
Safe and maximum doses according to regulators
Health Canada's monograph lists 500 – 4,000 milligrams of betaine, per day for adults, for liver function support.2 For betaine as a novel food, EFSA puts the maximum safe intake at 400 mg per day, or 6 mg/kg bw per day, in addition to the intake from the background diet.11 The EFSA level and the labelled homocystinuria dose concern different uses, EU novel-food use against a prescribed medicine.
Cycles, on-off schedules and logged doses
The Health Canada monograph states the duration of use needs no statement.2 Searches of DailyMed, ClinicalTrials.gov and PubMed returned no label or trial that defines on and off periods for betaine, and the labels give continuous dosing. Milligram's logs held no share of people logging betaine anhydrous, TMG or trimethylglycine to report.
Storage
The Eton label says to store the powder at 20 to 25 C, with excursions of 15 to 30 C permitted, and to protect it from moisture.1 Both labels say to take the mixture immediately and give no storage time or condition for a mixed solution.
Frequently asked questions
References
- DailyMed. These highlights do not include all the information needed to use BETAINE ANHYDROUS FOR ORAL SOLUTION safely and effectively. See full prescribing information for BETAINE ANHYDROUS FOR ORAL SOLUTION. BETAINE ANHYDROUS FOR ORAL SOLUTION Initial U.S. Approval: 1996. 2023. dailymed.nlm.nih.gov
- Health Canada. [TEMPLATE FOR SHORT FORM MONOGRAPHS (Jan 1st 2004)]. webprod.hc-sc.gc.ca
- DailyMed. These highlights do not include all the information needed to use CYSTADANE safely and effectively. See full prescribing information for CYSTADANE. CYSTADANE ® (betaine anhydrous for oral solution) Initial U.S. Approval: 1996. 2026. dailymed.nlm.nih.gov
- PubMed Central. Betaine supplementation improves CrossFit performance and increases testosterone levels, but has no influence on Wingate power: randomized crossover trial. 2023. pmc.ncbi.nlm.nih.gov
- PubMed Central. Effects of betaine on body composition, performance, and homocysteine thiolactone. 2013. pmc.ncbi.nlm.nih.gov
- PubMed Central. Betaine Supplementation Improves 60 km Cycling Time Trial Performance and One-Carbon Metabolism in Cyclists During Recovery. 2025. pmc.ncbi.nlm.nih.gov
- PubMed Central. Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial. 2022. pmc.ncbi.nlm.nih.gov
- PubMed Central. Metabolic Effects of Betaine: A Randomized Clinical Trial of Betaine Supplementation in Prediabetes. 2018. pmc.ncbi.nlm.nih.gov
- PubMed. Orally administered betaine has an acute and dose-dependent effect on serum betaine and plasma homocysteine concentrations in healthy humans. 2006. pubmed.ncbi.nlm.nih.gov
- PubMed. Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. 2002. pubmed.ncbi.nlm.nih.gov
- EFSA. Safety of betaine as a novel food pursuant to Regulation (EU) 2015/2283. 2019. pmc.ncbi.nlm.nih.gov